Evidence map›Paper›PMID 25197340›Full record

ArticleInternational journal of clinical and experimental pathology2014

Decreased intratumoral Foxp3 Tregs and increased dendritic cell density by neoadjuvant chemotherapy associated with favorable prognosis in advanced gastric cancer.

Min Hu, Kai Li, Ninu Maskey, Zhigao Xu, Chunwei Peng, Bicheng Wang, Yan Li, Guifang Yang

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. HighJournal of Cancer · 2021
    Article
  11. Article
  12. The Crosstalk between Microbiome and Immune Response in Gastric Cancer.International journal of molecular sciences · 2020
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Min HuDepartment of Pathology, Zhongnan Hospital of Wuhan University Wuhan 430071, China.
Kai LiDepartment of Pathology, Zhongnan Hospital of Wuhan University Wuhan 430071, China.
Ninu MaskeyDepartment of Pathology, Zhongnan Hospital of Wuhan University Wuhan 430071, China.
Zhigao XuDepartment of Pathology, Zhongnan Hospital of Wuhan University Wuhan 430071, China.
Chunwei PengDepartment of Oncology, Zhongnan Hospital of Wuhan University Wuhan 430071, China.
Bicheng WangDepartment of Pathology, Zhongnan Hospital of Wuhan University Wuhan 430071, China.
Yan LiDepartment of Oncology, Zhongnan Hospital of Wuhan University Wuhan 430071, China.
Guifang YangDepartment of Pathology, Zhongnan Hospital of Wuhan University Wuhan 430071, China.
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although neoadjuvant chemotherapy (NACT) has been increasingly used to improve the outcome of advanced gastric cancer (GC) for decades, its precise efficacy has been difficult to evaluate yet. Abundant studies have investigated the predictive factors that represent the effect of NACT on advanced GC. In the present study, the intratumoral infiltration of regulatory T cells (Tregs) and dendritic cells (DCs) response to NACT in advanced GC and their correlation with prognosis were evaluated. Infiltration of Tregs (marked by Foxp3) and DCs (marked by S-100) in 102 advanced GC specimens with or without NACT was measured using immunohistochemical method. Intratumoral infiltration of Foxp3 Tregs was significantly lower and DC density was significantly higher in NACT group than that in nNACT group (P=0.007, P=0.002, respectively). Infiltration of Foxp3 Tregs was significantly associated with tumor invasion depth (P<0.001). The DC density was significantly correlated with histopathologic type (P=0.035), invasion depth (P=0.002), TNM stage (P=0.018), and lymph node metastasis (P<0.001). There was no significant difference of patient's OS between NACT and nNACT groups (P=0.452); however, patients treated with NACT had longer OS with lower infiltration of Foxp3 Tregs (P<0.001) and higher infiltration of DCs (P=0.010). Univariate and multivariate analyses indicated that infiltration of Foxp3 Tregs and DCs were independent prognostic factors (P=0.002, P=0.003, respectively). The results demonstrated that NACT could decrease intratumoral Foxp3 Tregs infiltration and increase DCs density, and that infiltration of Foxp3 Tregs and DCs may serve as novel prognostic biomarkers of human GC.

Indexed as

Neoadjuvant TherapyAdultAgedAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantDendritic CellsFemaleFluorouracilForkhead Transcription FactorsHumansImmunohistochemistryKaplan-Meier EstimateLeucovorinLymphocytes, Tumor-InfiltratingMaleMiddle AgedFluorouracilForkhead Transcription FactorsFOXP3 protein, humanLeucovorinOrganoplatinum Compoundsadvanced gastric cancerdendritic cells (DCs)FOXP3Neoadjuvant chemotherapy (NACT)regulatory T cells (Tregs)S-100

Identifiers

PMID25197340
PMCPMC4152030
OpenAlexW2347208464

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.